BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Witkowski M, Wu Y, Hazen SL, Tang WHW. Prognostic value of subclinical myocardial necrosis using high-sensitivity cardiac troponin T in patients with prediabetes. Cardiovasc Diabetol 2021;20:171. [PMID: 34419046 DOI: 10.1186/s12933-021-01365-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Chaulin AM. Cardiac Troponins as Biomarkers of Cardiac Myocytes Damage in Case of Arterial Hypertension: From Pathological Mechanisms to Predictive Significance. Life 2022;12:1448. [DOI: 10.3390/life12091448] [Reference Citation Analysis]
2 Gumede N, Ngubane P, Khathi A. Assessing the risk factors for myocardial infarction in diet-induced prediabetes: myocardial tissue changes. BMC Cardiovasc Disord 2022;22:350. [PMID: 35918636 DOI: 10.1186/s12872-022-02758-8] [Reference Citation Analysis]
3 Son TK, Toan NH, Thang N, Le Trong Tuong H, Tien HA, Thuy NH, Van Minh H, Valensi P. Prediabetes and insulin resistance in a population of patients with heart failure and reduced or preserved ejection fraction but without diabetes, overweight or hypertension. Cardiovasc Diabetol 2022;21:75. [PMID: 35568879 DOI: 10.1186/s12933-022-01509-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Stultiens JMG, Top WMC, Kimenai DM, Lehert P, Bekers O, Stehouwer CDA, Kooy A, Meex SJR. Metformin and high-sensitivity cardiac troponin I and T trajectories in type 2 diabetes patients: a post-hoc analysis of a randomized controlled trial. Cardiovasc Diabetol 2022;21:49. [PMID: 35379238 DOI: 10.1186/s12933-022-01482-z] [Reference Citation Analysis]